In human SW982 synovial sarcoma cells (SSCs), EA induces TRPC1/C4 heterodimer activation and cell cytotoxicity, which is inhibited by Pico145, an inhibitor of the TRPC1/C4 channels. Here, C4A is linked to synovial sarcoma.